EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mouse Alport podocytes are susceptible to AAV9 transduction in vivo

Meei-Hua Lin, Kohei Omachi, Joshua F Begin, Jennifer L Richardson, Jeffrey H Miner

Kidney International · 2026-01 · 109 (1) · 129-138

DOI: 10.1016/j.kint.2025.09.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2026-01. Verfasst von Meei-Hua Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Podocytes, Dependovirus, Transduction, Genetic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, Children's Discovery Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Alport syndrome features a defective glomerular basement membrane (GBM) due to variants in COL4A3, COL4A4, and COL4A5. The most severe forms, which lack the GBM's collagen α3α4α5(IV) network, progress from hematuria in early childhood to proteinuria, chronic kidney disease, and kidney failure by the age of ∼30. As a monogenic disease without specific treatments, and with podocytes being the only glomerular cells that synthesize collagen α3α4α5(IV), the ability to efficiently deliver genes to Alport podocytes could open up new possibilities for treatment. METHODS: As a proof-of-concept study, we investigated whether podocytes in X-linked Alport mice were susceptible to transduction by adeno-associated virus (AAV)9. ssAAV9-CAG-tdTomato and scAAV9-CMV-Cre were intravenously injected into Col4a5-/y and Col4a5-/y; Ai14 (Cre-activatable tdTomato) Alport mice, respectively. The kidneys were collected two weeks later and subjected to quantification of podocyte transduction by fluorescence assays using synaptopodin as a podocyte marker. RESULTS: ssAAV9-CAG-tdTomato delivered to controls failed to transduce podocytes, but heterozygous female and hemizygous male Alport podocytes showed a range of transduction efficiencies, from 1.8% to 26%, which correlated positively with levels of albuminuria. Similar correlation between podocyte transduction and albuminuria was observed in the more sensitive Ai14 system with scAAV9-CMV-Cre administration. A subset of tubular and mesangial cells could also be transduced, the former in Alport mice and the latter in both Alport and control mice. CONCLUSIONS: The Alport GBM becomes leaky to AAV9 as mice mature, allowing viruses to reach and transduce a substantial subset of podocytes. This is promising for someday using AAV9 or other vehicles in gene therapy for patients with Alport syndrome. Interestingly, mesangial cells of control and young Alport mice were moderately susceptible to transduction, demonstrating that gene delivery to mesangial cells in mice is a viable approach for investigating mesangial cell biology in any context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, HereditaryPodocytesDependovirusTransduction, GeneticGenetic VectorsAnimalsCollagen Type IVDisease Models, AnimalMiceMaleMicrofilament ProteinsGlomerular Basement MembraneFemaleHumansGenetic Therapy

Stichwörter der Autor:innen

AAV9Alport syndromeglomerular basement membranepodocyte

Substanzen

Collagen Type IVCol4a5 protein, mouseMicrofilament ProteinsSynpo protein, mouse

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA; Laboratory for Tissue Microenvironment, RIKEN Center for Biosystems Dynamics Research (BDR), Kobe, Japa…
  • Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Electronic address: jeffminer@wustl.edu.

Förderung

  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • Children's Discovery Institute
  • Chinook Therapeutics
  • Oregon Health and Science University
  • Alport Syndrome Foundation
  • NIDDK
  • Japan Society for the Promotion of Science

Zitieren

APA

Lin, M. H., Omachi, K., Begin, J. F., Richardson, J. L., & Miner, J. H. (2026). Mouse Alport podocytes are susceptible to AAV9 transduction in vivo. Kidney International, 109(1), 129-138. https://doi.org/10.1016/j.kint.2025.09.027

Vancouver

Lin MH, Omachi K, Begin JF, Richardson JL, Miner JH. Mouse Alport podocytes are susceptible to AAV9 transduction in vivo. Kidney International. 2026;109(1):129-138. doi:10.1016/j.kint.2025.09.027

BibTeX
@article{Lin2026,
  author = {Lin, Meei-Hua and Omachi, Kohei and Begin, Joshua F and Richardson, Jennifer L and Miner, Jeffrey H},
  title = {Mouse Alport podocytes are susceptible to AAV9 transduction in vivo},
  journal = {Kidney International},
  year = {2026},
  volume = {109},
  number = {1},
  pages = {129--138},
  doi = {10.1016/j.kint.2025.09.027}
}
Kostenlos starten →